Clinical manifestations of Chikungunya fever in adult population: a brief descriptive study conducted in Caaguazú, Paraguay
DOI:
https://doi.org/10.53732/rccsalud/2024.e6701Keywords:
chikungunya fever, epidemic, symptomatology, adultAbstract
Introduction. Chikungunya virus (CHIKV) infection typically presents as an acute febrile illness that is self-limiting and predominantly characterized by severe polyarthralgia and myalgia. Objective. The purpose of this study was to describe the clinical characteristics of acute chikungunya virus infection in an adult population. Materials and Methods. This was a descriptive, cross-sectional, observational study. The study population included adults from a specific region of Paraguay during the CHIKV epidemic in 2022-2023. Inclusion criteria encompassed all patients who presented to the hospital within five days after developing typical symptoms of acute CHIKV infection, confirmed by RT-PCR, and after excluding the presence of dengue and Zika. Results. A total of 803 adults were included, with an average age of 45.13 ± 18.63 years and a male/female ratio of 1:1.79. At epidemiological weeks 8, 10, 11, 78, 120, and 132 cases were documented, respectively. The most common clinical manifestations were fever in 97% of the cases (n=583), arthralgia and arthritis in 86.03% (n=653), myalgias in 77.08% (n=585), and headache in 73.91% (n=561). There were 6 deaths (0.75% of the total cases). Conclusion. The clinical presentation of CHIKV during the 2023 epidemic in Paraguay is consistent with previous descriptions in other regions. The disease generated a significant number of medical consultations and led to saturation of the public health system, which was fatal in a small percentage of cases.
References
Bartholomeeusen K, Daniel M, LaBeaud DA, Gasque P, Peeling RW, Stephenson KE, et al. Chikungunya fever. Nat Rev Dis Primers. 2023;9(1):17. https://doi.org/10.1038/s41572-023-00429-2
Zaid A, Burt FJ, Liu X, Poo YS, Zandi K, Suhrbier A, et al. Arthritogenic alphaviruses: epidemiological and clinical perspective on emerging arboviruses. Lancet Infect Dis. 2021;21(5):e123-e133. https://doi.org/10.1016/S1473-3099(20)30491-6
Laporta GZ, Potter AM, Oliveira JFA, Bourke BP, Pecor DB, Linton YM. Global Distribution of Aedes aegypti and Aedes albopictus in a Climate Change Scenario of Regional Rivalry. Insects. 2023;14(1):49. https://doi.org/10.3390/insects14010049
Paul BJ, Sadanand S. Chikungunya Infection: A Re-emerging Epidemic. Rheumatol Ther. 2018;5(2):317-326. https://doi.org/10.1007/s40744-018-0121-7
Sharp TM, Keating MK, Shieh WJ, Bhatnagar J, Bollweg BC, Levine R, et al. Clinical Characteristics, Histopathology, and Tissue Immunolocalization of Chikungunya Virus Antigen in Fatal Cases. Clin Infect Dis. 2021;73(2):e345-e354. https://doi.org/10.1093/cid/ciaa837
Roy E, Shi W, Duan B, Reid SP. Chikungunya Virus Infection Impairs the Function of Osteogenic Cells. mSphere. 2020;5(3):e00347-20. https://doi.org/10.1128/mSphere.00347-20
Amaral JK, Bilsborrow JB, Schoen RT. Chronic Chikungunya Arthritis and Rheumatoid Arthritis: What They Have in Common. Am J Med. 2020;133(3):e91-e97. https://doi.org/10.1016/j.amjmed.2019.10.005
Chang AY, Martins KAO, Encinales L, Reid SP, Acuña M, Encinales C, et al. Chikungunya Arthritis Mechanisms in the Americas: A Cross-Sectional Analysis of Chikungunya Arthritis Patients Twenty-Two Months After Infection Demonstrating No Detectable Viral Persistence in Synovial Fluid. Arthritis Rheumatol. 2018;70(4):585-593. https://pubmed.ncbi.nlm.nih.gov/29266856/
de Lima Cavalcanti TYV, Pereira MR, de Paula SO, Franca RFO. A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development. Viruses. 2022;14(5):969. https://doi.org/10.3390/v14050969
Dorléans F, Hoen B, Najioullah F, Herrmann-Storck C, Schepers KM, Abel S, et al. Outbreak of Chikungunya in the French Caribbean Islands of Martinique and Guadeloupe: Findings from a Hospital-Based Surveillance System (2013-2015). Am J Trop Med Hyg. 2018;98(6):1819-1825. https://doi.org/10.4269/ajtmh.16-0719
Silva Junior GBD, Pinto JR, Mota RMS, Pires Neto RDJ, Daher EF. Impact of Chronic Kidney Disease on Chikungunya Virus Infection Clinical Manifestations and Outcome: Highlights during an Outbreak in Northeastern Brazil. Am J Trop Med Hyg. 2018;99(5):1327-1330. https://doi.org/10.4269/ajtmh.18-0531
Freitas ARR, Alarcón-Elbal PM, Paulino-Ramírez R, Donalisio MR. Excess mortality profile during the Asian genotype chikungunya epidemic in the Dominican Republic, 2014. Trans R Soc Trop Med Hyg. 2018;112(10):443-449. https://doi.org/10.1093/trstmh/try072
Ministerio de Salud Pública y Bienestar Social. Boletín Epidemiológico Semanal – Semana Epidemiológica 11. 2024. https://dgvs.mspbs.gov.py/wp-content/uploads/2024/03/SE-11_Boletin-Epidemiologico-Semanal_DGVS.pdf
Vairo F, Haider N, Kock R, Ntoumi F, Ippolito G, Zumla A. Chikungunya: Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention. Infect Dis Clin North Am. 2019;33(4):1003-1025. https://doi.org/10.1016/j.idc.2019.08.006
Montiel-Jarolín D, Samudio M, Torres E, Jarolín M, Taboada V, Sánchez L. Características clínicas y laboratoriales de pacientes adultos ambulatorios con Chikungunya del Hospital Nacional de Itauguá de Paraguay durante la epidemia 2022-2023. Med. clín. soc. 2023;7(3):161-167. https://doi.org/10.52379/mcs.v7i3.322
Rueda JC, Santos AM, Angarita JI, Giraldo RB, Saldarriaga EL, Ballesteros Muñoz JG, et al. Demographic and clinical characteristics of chikungunya patients from six Colombian cities, 2014-2015. Emerg Microbes Infect. 2019;8(1):1490-1500. https://pubmed.ncbi.nlm.nih.gov/31631794/
van Genderen FT, Krishnadath I, Sno R, Grunberg MG, Zijlmans W, Adhin MR. First Chikungunya Outbreak in Suriname; Clinical and Epidemiological Features. PLoS Negl Trop Dis. 2016;10(4):e0004625. https://doi.org/10.1371/journal.pntd.0004625
Liu LB, Li M, Gao N, Shen JY, Sheng ZY, Fan DY, et al. An J. Epidemiological and clinical characteristics of the chikungunya outbreak in Ruili City, Yunnan Province, China. J Med Virol. 2022;94(2):499-506. https://doi.org/10.1002/jmv.27302
Imad HA, Phadungsombat J, Nakayama EE, Suzuki K, Ibrahim AM, Afaa A, et al. Clinical Features of Acute Chikungunya Virus Infection in Children and Adults during an Outbreak in the Maldives. Am J Trop Med Hyg. 2021;105(4):946-954. https://doi.org/10.4269/ajtmh.21-0189
Rahman MM, Been Sayed SJ, Moniruzzaman M, Kabir AKMH, Mallik MU, Hasan MR, et al. Clinical and Laboratory Characteristics of an Acute Chikungunya Outbreak in Bangladesh in 2017. Am J Trop Med Hyg. 2019;100(2):405-410. https://doi.org/10.4269/ajtmh.18-0636
Lizarazo E, Vincenti-Gonzalez M, Grillet ME, Bethencourt S, Diaz O, Ojeda N, et al. Spatial Dynamics of Chikungunya Virus, Venezuela, 2014. Emerg Infect Dis. 2019;25(4):672-680. https://doi.org/10.3201/eid2504.172121
Ministerio de Salud Pública y Bienestar Social. Guía de manejo clínico y tratamiento de la Enfermedad por virus Chikunguya. 2023. https://fpgo.org.py/wp-content/uploads/2023/04/Guia-de-manejo-clinico-de-la-chikungunya-MSPyBS-31032023.pdf
Freitas ARR, Gérardin P, Kassar L, Donalisio MR. Excess deaths associated with the 2014 chikungunya epidemic in Jamaica. Pathog Glob Health. 2019;113(1):27-31. https://pubmed.ncbi.nlm.nih.gov/30714498/
.png)
All the contents of this journal are licensed under a 